Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc > KRC insight
View:
Post by Pandemic2021 on Mar 22, 2022 10:33am

KRC insight

Bruce Krugel has updated price target for MBX: https://microbix.com/wp-content/uploads/
Comment by wizzdumb on Mar 22, 2022 11:41am
There is no new information posted.  Volume has completely dropped off again. Almost midday and not a single trade.  Selling is done for now, called the bottom correctly. Now we wait for news. AGM next Wednesday. 
Comment by rjc7 on Mar 22, 2022 7:48pm
Link won't open.  Can you open, copy and paste.  Thanks 
Comment by RazeKreations on Mar 23, 2022 1:35am
https://microbix.com/analyst-coverage/
Comment by Pandemic2021 on Mar 23, 2022 10:35am
KRC insight 1 year price Target increase to $2.05 for Q1 F2022. The report is available on LinkedIn.
Comment by Pandemic2021 on Mar 23, 2022 11:49am
You can download the PDF from this link - https://file.io/cq2RMP42RH9S
Comment by Mbxwatcher on Mar 23, 2022 11:49am
Read the entire report.   Well documented and well thought out. Here I will throw myself on the proverbial sword.: I beilieve I stated on more than one occassion that I was afraid that the company was withholding this report because it was paid research and they did not have to publish it.   I was wrong on this point. He deals extensively with the perception of MBX as a Covid ...more  
Comment by wizzdumb on Mar 23, 2022 2:23pm
If anything the estimates are conservative. As I've said many times here, if they are to be believed at all the business is out there and now they just need to complete the expansion and deliver the goods in the form of continued record results. The market can be slow to recognize performance but always catches on and rewards at some point. Keep winding that spring Cameron and team, when it ...more  
Comment by Mbxwatcher on Mar 24, 2022 1:22pm
A quick mention in the Globe and Mail today, along with Pfizer, Thermo Fisher Scientific and Eli Lilly and Co.... and interesting article quoting Eden Rahim, and Chelsea Stellick.  Good exposure for a micro cap being mentioned in same article as the Giants.   Looking ahead, Chelsea Stellick, Calgary-based iA Capital Markets senior equity research analyst focused on health care and ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities